SPRUCE BIOSCIENCES, INC.

Profile

Company Names

SPRUCE BIOSCIENCES, INC.

Addresses

611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA 94080

2001 JUNIPERO SERRA BOULEVARD, SUITE 640, DALY CITY, CA 94014

1700 MONTGOMERY ST. STE. 212, SAN FRANCISCO, CA 94111

Phone Numbers

(415) 655-4168
(415) 294-1687
4152941687

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$191,615,488.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-10-09 
$49,999,768.00 
$49,999,768.00 
$0.00 
Equity 
2
2023-02-16 
$53,615,720.00 
$53,615,720.00 
$0.00 
Equity 
1
2020-02-19 
$88,000,000.00 
$88,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIBA 
 
AYNECHI 
DIRECTOR
THESAN PHARMACEUTICALS, INC.   |  IRHYTHM TECHNOLOGIES, INC.   |  ANAPTYSBIO INC   |  GENOA PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  ARCELLX, INC.   |  NKARTA, INC.   |  AVALYN PHARMA INC.   |  SPRUCE BIOSCIENCES, INC.   |  ARISTEA THERAPEUTICS, INC.   |  MBX BIOSCIENCES, INC.   |  REZO THERAPEUTICS, INC.   |  RAY THERAPEUTICS, INC.
PERCIVAL 
 
BARRETTO-KO 
DIRECTOR
SPRUCE BIOSCIENCES, INC.
SIMPSON 
 
CAMILLA 
DIRECTOR
SPRUCE BIOSCIENCES, INC.
RALPH 
WILLIAM 
CHARLTON III 
EXECUTIVE OFFICER
SPRUCE BIOSCIENCES, INC.
DINA 
 
CHAYA 
DIRECTOR
SPRUCE BIOSCIENCES, INC.
SAMIR 
 
GHARIB 
EXECUTIVE OFFICER
SPRUCE BIOSCIENCES, INC.
MICHAEL 
 
GREY 
DIRECTOR, EXECUTIVE OFFICER
AUSPEX PHARMACEUTICALS, INC.   |  ACHILLION PHARMACEUTICALS INC   |  LUMENA PHARMACEUTICALS, INC.   |  SELVENTA, INC.   |  HORIZON PHARMA, INC.   |  BALANCE THERAPEUTICS, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  RENEO PHARMACEUTICALS, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  SPRUCE BIOSCIENCES, INC.   |  SORRISO PHARMACEUTICALS, INC.   |  PLEXIUM, INC.
JONAS 
 
HANSSON 
DIRECTOR
REVENT MEDICAL, INC.   |  SPRUCE BIOSCIENCES, INC.
RICHARD 
 
KING 
EXECUTIVE OFFICER, DIRECTOR
CORTRIA CORP   |  ACELRX PHARMACEUTICALS INC   |  TETON EQUITY PARTNERS, LP   |  TETON EQUITY PARTNERS II, LP   |  SPRUCE BIOSCIENCES, INC.
BALI 
 
MURALIDHAR 
DIRECTOR
SPRUCE BIOSCIENCES, INC.   |  RENEO PHARMACEUTICALS, INC.   |  WUGEN, INC.
NIALL 
 
O-DONNELL 
DIRECTOR
LYRIC PHARMACEUTICALS INC.   |  3X5 RIVERVEST FUND II, L.P.   |  ARCHER SEED FUND, L.P.   |  GENOA PHARMACEUTICALS, INC.   |  RENEO PHARMACEUTICALS, INC.   |  RIVERVEST VENTURE FUND IV, L.P.   |  CURZION PHARMACEUTICALS, INC.   |  SPRUCE BIOSCIENCES, INC.   |  AVALYN PHARMA INC.   |  MIRUM PHARMACEUTICALS, INC.   |  RIVERVEST VENTURE FUND V, L.P.   |  SPARROW PHARMACEUTICALS, INC.   |  WUGEN, INC.
CAMILLA 
 
SIMPSON 
DIRECTOR
SPRUCE BIOSCIENCES, INC.   |  GRI BIO, INC.
DANIEL 
 
SPIEGELMAN 
DIRECTOR
AFFYMAX INC   |  ONCOTHYREON INC.   |  SPRUCE BIOSCIENCES, INC.
JAVIER 
 
SZWARCBERG 
EXECUTIVE OFFICER, DIRECTOR
SPRUCE BIOSCIENCES, INC.
KIRK 
 
WAYS 
DIRECTOR
SPRUCE BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2025-10-09 
2023-02-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2023-02-16 
2020-08-14
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NOT APPLICABLE 
Equity 
2020-02-19 
2020-02-28
D
Link
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Equity 
2020-02-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
39011
NONE
NONE
CITIZENS JMP SECURITIES, LLC
22208
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
SVB SECURITIES LLC
39011